These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36569038)

  • 41. Restless Legs Syndrome After Single Low Dose Quetiapine Administration.
    Soyata AZ; Celebi F; Yargc LI
    Curr Drug Saf; 2016; 11(2):172-3. PubMed ID: 26582164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The relationship among restless legs syndrome (Willis-Ekbom Disease), hypertension, cardiovascular disease, and cerebrovascular disease.
    Ferini-Strambi L; Walters AS; Sica D
    J Neurol; 2014 Jun; 261(6):1051-68. PubMed ID: 23963470
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dopaminergic Augmentation in Restless Legs Syndrome/Willis-Ekbom Disease: Identification and Management.
    García-Borreguero D
    Sleep Med Clin; 2015 Sep; 10(3):287-92, xiii. PubMed ID: 26329438
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Key sleep neurologic disorders: Narcolepsy, restless legs syndrome/Willis-Ekbom disease, and REM sleep behavior disorder.
    St Louis EK
    Neurol Clin Pract; 2014 Feb; 4(1):16-25. PubMed ID: 24605270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential Diagnoses of Restless Legs Syndrome/Willis-Ekbom Disease: Mimics and Comorbidities.
    Chokroverty S
    Sleep Med Clin; 2015 Sep; 10(3):249-62, xii. PubMed ID: 26329435
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Are serum ferritin and transferrin saturation risk markers for restless legs syndrome in young adults? Longitudinal and cross-sectional data from the Western Australian Pregnancy Cohort (Raine) Study.
    Lammers N; Curry-Hyde A; Smith AJ; Eastwood PR; Straker LM; Champion D; McArdle N
    J Sleep Res; 2019 Oct; 28(5):e12741. PubMed ID: 30062860
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of Restless Legs Syndrome/Willis-Ekbom Disease in Hospitalized and Perioperative Patients.
    Goldstein C
    Sleep Med Clin; 2015 Sep; 10(3):303-10, xiv. PubMed ID: 26329440
    [TBL] [Abstract][Full Text] [Related]  

  • 48. F-Wave Duration as a Specific and Sensitive Tool for the Diagnosis of Restless Legs Syndrome/Willis-Ekbom Disease.
    Congiu P; Fantini ML; Milioli G; Tacconi P; Figorilli M; Gioi G; Pereira B; Marrosu F; Parrino L; Puligheddu M
    J Clin Sleep Med; 2017 Mar; 13(3):369-375. PubMed ID: 28095964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The experience of living with restless legs syndrome: A qualitative study.
    Harrison EG; Keating JL; Morgan PE
    J Health Psychol; 2021 Jul; 26(8):1154-1167. PubMed ID: 31434518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopaminergic Therapy for Restless Legs Syndrome/Willis-Ekbom Disease.
    Zak RS; Walters AS
    Sleep Med Clin; 2015 Sep; 10(3):279-85, xiii. PubMed ID: 26329437
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Restless legs syndrome following the use of ziprasidone: a case report.
    Zhu C; Bi R; Hu Y; Zhou H; Zhu D; Isaacson B; Li Q; Lin Y
    Gen Psychiatr; 2020; 33(2):e100112. PubMed ID: 32215360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Restless legs syndrome from the perspective of psychiatry].
    Rubí G P
    Rev Med Chil; 2018 Sep; 146(9):1041-1049. PubMed ID: 30725026
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unraveling the Mysteries of Restless Leg Syndrome.
    Memon MD; Faiz S; Zaveri MP; Perry JC; Schuetz TM; Cancarevic I
    Cureus; 2020 Oct; 12(10):e10951. PubMed ID: 33083159
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comorbidities, treatment, and pathophysiology in restless legs syndrome.
    Trenkwalder C; Allen R; Högl B; Clemens S; Patton S; Schormair B; Winkelmann J
    Lancet Neurol; 2018 Nov; 17(11):994-1005. PubMed ID: 30244828
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impaired vascular endothelial function in patients with restless legs syndrome: a new aspect of the vascular pathophysiology.
    Koh SY; Kim MS; Lee SM; Hong JM; Yoon JH
    J Neurol Sci; 2015 Dec; 359(1-2):207-10. PubMed ID: 26671114
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sensorimotor white matter projections and disease severity in primary Restless Legs Syndrome/Willis-Ekbom disease: a multimodal DTI analysis.
    de Paiva JPQ; Magalhães SC; Moura LM; Sato JR; Amaro E; Sterr A; Schlaffke L; Eckeli AL; do Prado GF; Conforto AB
    Sleep Med; 2020 Sep; 73():106-116. PubMed ID: 32805477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emerging Concepts of the Pathophysiology and Adverse Outcomes of Restless Legs Syndrome.
    Romero-Peralta S; Cano-Pumarega I; García-Borreguero D
    Chest; 2020 Sep; 158(3):1218-1229. PubMed ID: 32247713
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Consensus clinical practice guidelines for the diagnosis and treatment of restless legs syndrome/Willis-Ekbom disease during pregnancy and lactation.
    Picchietti DL; Hensley JG; Bainbridge JL; Lee KA; Manconi M; McGregor JA; Silver RM; Trenkwalder C; Walters AS;
    Sleep Med Rev; 2015 Aug; 22():64-77. PubMed ID: 25553600
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and quality of life and sleep in children and adolescents with restless legs syndrome/Willis-Ekbom disease.
    Sander HH; Eckeli AL; Costa Passos AD; Azevedo L; Fernandes do Prado LB; França Fernandes RM
    Sleep Med; 2017 Feb; 30():204-209. PubMed ID: 28215250
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.